Novartis Report Positive Topline Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

with 75mg the planned dose for further development Ensovibep continues to maintain potent in vitro pan-variant activity against all variants of concern identified so. | January 10, 2022

South africaUnited statesShai biranSeth lewisThomas schneckenburgerPatrick amstutzExchange commissionDrug administrationMolecular partnersNovartis report positive topline dataAntiviral therapeuticDesigned ankyrin repeat proteinEmergency use authorizationEmergency roomVas narasimhanDesigned ankyrin repeat proteins